Connect with us

Life Sciences

Innofiber Announces Dustin Gorman as New CEO

Innofiber appoints CEO with track record of growing B2B medical device and industrials businesses Innofiber, a leading supplier and manufacturer of fiber…

Published

on

This article was originally published by AITHORITY
Innofiber Announces Dustin Gorman as New CEO

Innofiber appoints CEO with track record of growing B2B medical device and industrials businesses

Innofiber, a leading supplier and manufacturer of fiber optic cables and engineered photonic solutions, announces that Dustin T. Gorman will now lead the organization as Chief Executive Officer.

Mr. Gorman said: “I am thrilled to be joining the Innofiber team. Thanks to Innofiber’s commitment to innovative technology, lean manufacturing practices, and the leadership of the management team, the company is poised to scale to meet the needs of its customers and further its leadership in engineered photonic solutions. Innofiber has a strong tradition of delivering advanced, modern solutions for their customers’ most complex product needs, and I am excited to help take the company to the next level.”

AI NewsAn Investment Into Artificial Intelligence as Daktela Buys Coworkers.ai

Mr. Gorman’s experience has equipped him with a strong understanding of the dynamic market landscape and the ability to expand Innofiber’s business within it. He brings a wealth of experience in the medical device, semiconductor and industrial markets as a business leader and engineer. He joins Innofiber from Prodrive Technologies, a manufacturer of high-tech electronics, software, and mechatronic products and systems, where he was General Manager for Prodrive Technologies North America. In his role, Gorman helped launch Prodrive’s U.S. business, oversaw the build out of a new North American Regional Headquarters in Canton, Massachusetts, and won several new major OEM applications across Power Conversion, Motion & Mechatronics, and IoT technology/product programs. Prior to Prodrive, Gorman spent over 9 years at Analogic, a leader in healthcare and security technology solutions for the medical sector, as Director of Business Development and Application Engineer, where he worked with multiple leading medical device, motion control, and robotics players. Before Analogic, Gorman served as Electro-Optical Laser Ordnance Section Chief for the U.S. Marine Corps and held engineering positions at Copley Controls Corp and in the U.S. Marine Corps Reserve.

Latest AI/NLP Technology Insights: ProcessUnity Acquires AI/NLP Technology from ISMS Solutions

Franklin Foster, Partner at Essex Bay Capital said: “Dustin has a track record of driving growth and creating value for a range of medical and industrial customers, and his deep technical knowledge makes him an ideal partner for Innofiber’s customers and other leaders in these dynamic markets. Together with Dustin, we look forward to scaling Innofiber organically and through acquisitions.”

Gorman received an MOS in Electro-Optical Laser Ordnance from the U.S. Army Ordnance Center and School, a BSEET in Electronics Engineering from the New England Institute of Technology, and an MBA from the D’Amore-McKim School of Business at Northeastern University.

Latest Aithority Insights : Got It AI Announces AutoFlows, a Breakthrough Autonomous Conversational AI

 [To share your insights with us, please write to sghosh@martechseries.com] 

The post Innofiber Announces Dustin Gorman as New CEO appeared first on AiThority.





artificial intelligence



Life Sciences

Wittiest stocks:: Avalo Therapeutics Inc (NASDAQ:AVTX 0.00%), Nokia Corp ADR (NYSE:NOK 0.90%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Spellbinding stocks: LumiraDx Limited (NASDAQ:LMDX 4.62%), Transocean Ltd (NYSE:RIG -2.67%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner

The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….

Continue Reading

Trending